A new therapeutic ap-proach for treating of bisphosphonate associ-ated osteonecrosis of the jaws (BP-ONJ)

The administration of bisphosphonates is always necessary if a disease with high levels of bone resorption is given. Osteone-crosis of the jaws can arise as a contraindi-cation. This clinical picture is explained by a reduced bone turnover caused by bisphos-phonates. To date it has not been possible to develop specific therapies. The accom-plished symptomatic treatment is currently limited to antibiotic administration, mouth-washes and in the worst case operational removal of the necrotic tissue.

It was now possible to demonstrate that the administration of an agent, which is already available, can raise the viability of os-teoblasts significantly. So the agent enables to work against the osteonecrosis in an early state.

Further Information: PDF

IMG Innovations-Management GmbH
Phone: +49 (0)631/31668-50

Contact
Dr. Klaus Kobek

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

A universal framework for spatial biology

SpatialData is a freely accessible tool to unify and integrate data from different omics technologies accounting for spatial information, which can provide holistic insights into health and disease. Biological processes…

How complex biological processes arise

A $20 million grant from the U.S. National Science Foundation (NSF) will support the establishment and operation of the National Synthesis Center for Emergence in the Molecular and Cellular Sciences (NCEMS) at…

Airborne single-photon lidar system achieves high-resolution 3D imaging

Compact, low-power system opens doors for photon-efficient drone and satellite-based environmental monitoring and mapping. Researchers have developed a compact and lightweight single-photon airborne lidar system that can acquire high-resolution 3D…

Partners & Sponsors